DarioHealth Pretax Profit Margin from 2010 to 2024
| DRIO Stock | USD 1.50 0.05 3.45% |
Pretax Profit Margin | First Reported 2010-12-31 | Previous Quarter (2.92) | Current Value (3.06) | Quarterly Volatility 121.44491303 |
Check DarioHealth Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DarioHealth main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.5 M, Interest Expense of 0.0 or Selling General Administrative of 9.6 M, as well as many exotic indicators such as Price To Sales Ratio of 2.28, Dividend Yield of 0.19 or PTB Ratio of 0.71. DarioHealth financial statements analysis is a perfect complement when working with DarioHealth Corp Valuation or Volatility modules.
DarioHealth | Pretax Profit Margin |
Latest DarioHealth Corp's Pretax Profit Margin Growth Pattern
Below is the plot of the Pretax Profit Margin of DarioHealth Corp over the last few years. It is DarioHealth Corp's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DarioHealth Corp's overall financial position and show how it may be relating to other accounts over time.
| Pretax Profit Margin | 10 Years Trend |
|
Pretax Profit Margin |
| Timeline |
DarioHealth Pretax Profit Margin Regression Statistics
| Arithmetic Mean | (86.58) | |
| Coefficient Of Variation | (140.27) | |
| Mean Deviation | 110.61 | |
| Median | (3.88) | |
| Standard Deviation | 121.44 | |
| Sample Variance | 14,749 | |
| Range | 250 | |
| R-Value | 0.82 | |
| Mean Square Error | 5,153 | |
| R-Squared | 0.68 | |
| Significance | 0.0002 | |
| Slope | 22.32 | |
| Total Sum of Squares | 206,484 |
DarioHealth Pretax Profit Margin History
About DarioHealth Corp Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include DarioHealth Corp income statement, its balance sheet, and the statement of cash flows. DarioHealth Corp investors use historical funamental indicators, such as DarioHealth Corp's Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Although DarioHealth Corp investors may use each financial statement separately, they are all related. The changes in DarioHealth Corp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on DarioHealth Corp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on DarioHealth Corp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in DarioHealth Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (2.92) | (3.06) |
Pair Trading with DarioHealth Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.Moving against DarioHealth Stock
| 0.77 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.75 | ELEV | Elevation Oncology Earnings Call Next Week | PairCorr |
| 0.74 | AGTI | Agiliti Financial Report 14th of May 2024 | PairCorr |
| 0.69 | NXL | Nexalin Technology | PairCorr |
| 0.63 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of DarioHealth Corp Correlation against competitors. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for DarioHealth Stock analysis
When running DarioHealth Corp's price analysis, check to measure DarioHealth Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DarioHealth Corp is operating at the current time. Most of DarioHealth Corp's value examination focuses on studying past and present price action to predict the probability of DarioHealth Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DarioHealth Corp's price. Additionally, you may evaluate how the addition of DarioHealth Corp to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is DarioHealth Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.93) | Revenue Per Share 0.717 | Quarterly Revenue Growth (0.47) | Return On Assets (0.33) | Return On Equity (0.86) |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.